… In conclusion, in patients with moderate COPD and heightened cardiovascular risk, treatment
with fluticasone furoate and vilanterol does not affect mortality or cardiovascular outcomes, …

… risk for a broad range of cardiac events and all-cause death, persisting for 1 year or more,
including first and subsequent exacerbations, emphasise the burden of cardiopulmonary risk …

… We explore how traditional cardiovascular risk factors, novel cardiovascular risk factors, and
social determinants of health may contribute to the excess ASCVD risk seen in South Asian …

… in all hypertensive patients so as to offer a more precise measure of cardiovascular risk
and enable selection of targeted therapy to achieve optimal cardiovascular outcomes. …

… risk for CVD, women at menopause are also at a greater risk … obesity, which further elevates
cardiovascular risk factors in both … Because of the heightened cardiovascular risks in women …

… It is possible that occult CVD led to heightened cardiovascular response so that previous
disease status caused disturbances in responsivity rather than the reverse. In addition, …

… of increased cardiovascular risk, as it reflects a heightened sympathetic activity. … risk factor,
and that it can promote the development of atherosclerotic lesions and favour cardiovascular …

… Research on the risk of cardiovascular disease among … with a high risk of cardiovascular
disease complications may … had a heightened risk profile for cardiovascular disease, to …

… epidemic continuing to start at younger ages and the continued lack of physical activity in
many young adults, there are likely many young adults that are at heightened long-term risk. …

… risk identified a statistically significant greater relative risk for … risk persisted after statistical
adjustment for other cardiac risk … diabetes per se—not greater risk factor aggregation, severity, …